DrugPatentWatch Database Preview
Ampicillin sodium - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for ampicillin sodium and what is the scope of freedom to operate?
Ampicillin sodium
is the generic ingredient in seven branded drugs marketed by Acs Dobfar Spa, Antibiotice, Apothecon, Aurobindo Pharma, Consolidated Pharm, Hanford Gc, Hospira Inc, Intl Medication, Istituto Bio Ita Spa, Lilly, Mylan Labs Ltd, Sagent Pharms Inc, Sandoz, Watson Labs Inc, West-ward Pharms Int, Wyeth Ayerst, Bristol, Glaxosmithkline, Acs Dobfar, Astral, Mustafa Nevzat Ilac, and Pfizer, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.There are seventy drug master file entries for ampicillin sodium. Sixteen suppliers are listed for this compound.
Summary for ampicillin sodium
US Patents: | 0 |
Tradenames: | 7 |
Applicants: | 22 |
NDAs: | 56 |
Drug Master File Entries: | 70 |
Suppliers / Packagers: | 16 |
Bulk Api Vendors: | 99 |
Clinical Trials: | 8 |
Patent Applications: | 6,814 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ampicillin sodium at DailyMed |
Recent Clinical Trials for ampicillin sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
DongGuk University | N/A |
Federal University of São Paulo | Phase 4 |
Pharmacology for ampicillin sodium
Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for ampicillin sodium
Synonyms for ampicillin sodium
(2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid |
(2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
(2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
(2S,5R,6R)-6-[(R)-2-Amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sodium salt |
(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID |
1h8s |
2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid |
33604-21-6 |
37234-64-3 |
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2R)-aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S,5R,6R)- |
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))- |
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2S-(2alpha,5alpha,6beta(S*)))- |
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, D-(-)- |
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, sodium salt, D-(-)- |
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)- |
47355-94-2 |
50584-05-9 |
6-((2R)-2-amino-2-phenylacetylamino)(2S,5R,6R)-3,3-dimethyl-7-oxo-4-thia-1-aza bicyclo[3.2.0]heptane-2-carboxylic acid |
6-((2R)-2-amino-2-phenylacetylamino)(2S,5R,6R)-3,3-dimethyl-7-oxo-4-thia-1-aza bicyclo[3.2.0]heptane-2-carboxylic acid, oxamethane, oxamethane, oxamethane |
6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-,sodiumsalt,d-(-)-4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid |
6-(a-Aminophenylacetamido)penicillanic acid |
6-(D-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid |
6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid |
6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI |
6-D(-)-alpha-Aminophenylacetamido-penicillanic acid |
69-52-3 |
69-52-3 (mono-hydrochloride salt) |
69-52-3,24863-47-6,57748-55-7,69-53-4(freebase) |
69-53-4 |
69-53-4 (Parent) |
6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid |
7177-48-2 (TRIHYDRATE) |
7C782967RD |
800-79-3 |
8056-87-9 |
96707-69-6 |
98520-55-9 |
AB-PC |
AB-PC Sol |
ABPC |
AC-8805 |
AC-8806 |
AC1L1M46 |
Acillin |
Adobacillin |
AKOS015888156 |
AKOS015967315 |
AKOS025147373 |
Alpen |
Alpen-N |
Alpha-Aminobenzylpenicillin |
Amblosin |
Amcill |
Amcill-S |
Amfipen |
Amfipen V |
Aminobenzylpenicillin |
AMINOBENZYLPENICILLIN SODIUM SALT |
Amipenix S |
Ampen |
AMPI |
Ampi-bol |
Ampi-Co |
Ampi-Tab |
Ampichel |
Ampicil |
Ampicilina |
Ampicilina [INN-Spanish] |
ampicillanyl |
ampicillin |
Ampicillin (anhydrous) |
AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2) |
Ampicillin (sodium) |
Ampicillin (USP/INN) |
Ampicillin [USAN:BAN:INN:JAN] |
Ampicillin [USAN:INN:BAN:JAN] |
Ampicillin [USAN:USP:INN:BAN:JAN] |
Ampicillin A |
Ampicillin acid |
Ampicillin anhydrate |
Ampicillin Anhydrous |
AMPICILLIN ANHYDROUS, PHARMACEUTICAL GRADE |
Ampicillin Base |
Ampicillin Na |
Ampicillin natrium |
Ampicillin sodium (JP17/USP) |
Ampicillin sodium [USAN:USP:JAN] |
Ampicillin sodium salt |
Ampicillin Sodium Salt, Antibiotic for Culture Media Use Only |
Ampicillin sodium salt, cell culture grade |
Ampicillin, analytical standard |
Ampicillin, anhydrous |
Ampicillin, anhydrous, 96.0-100.5% (anhydrous basis) |
Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard |
Ampicillin, United States Pharmacopeia (USP) Reference Standard |
Ampicillin,(S) |
AMPICILLIN; D(-)-ALPHA-AMINOBENZYLPENICILLIN; 6-[D(-)-ALPHA-AMINOPHENYLLACETAMIDO]PENICILLANIC ACID |
AMPICILLIN/AMPICILLIN TRIHYDRATE |
Ampicillina |
Ampicillina [DCIT] |
Ampicilline |
Ampicilline [INN-French] |
Ampicillinsodium |
Ampicillinum |
Ampicillinum [INN-Latin] |
Ampicin |
Ampifarm |
Ampikel |
Ampimed |
Ampipenin |
Ampipenin, nt3 |
Ampiplus Simplex |
Ampiscel |
Ampisyn |
Ampivax |
Ampivet |
Amplacilina |
Amplin |
Amplipenyl |
Amplisom |
Amplital |
Ampy-Penyl |
AN-7670 |
anhydrous ampicillin |
Anhydrous ampicillin (JP17) |
Anhydrous ampicillin, British Pharmacopoeia (BP) Reference Standard |
API0001474 |
Austrapen |
AVKUERGKIZMTKX-NJBDSQKTSA-N |
AY 6108 |
AY 6108 |
AY-6108 |
BA 7305 |
Bayer 5427 |
BDBM50350465 |
BIA0104 |
BIDD:GT0184 |
Binotal |
Binotal sodium |
Bonapicillin |
BPBio1_000142 |
BRD-K68432770-001-08-0 |
Britacil |
BRL 1341 |
BRL-1341 |
BSPBio_000128 |
BSPBio_001862 |
C-20591 |
C-21155 |
C06574 |
C13652 |
Campicillin |
CAS-69-53-4 |
CC-24106 |
CC-24107 |
CCG-39691 |
CHEBI:28971 |
CHEBI:34535 |
CHEBI:53713 |
CHEMBL1200758 |
CHEMBL174 |
Cimex |
Citteral |
Copharcilin |
CPD000058352 |
CS-2741 |
CS-2742 |
CTK2F3032 |
D-(-)-.alpha.-Aminobenzylpenicillin |
D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid |
D-(-)-alpha-Aminobenzylpenicillin |
D-(-)-alpha-Aminobenzylpenicillin sodium salt |
D-(-)-alpha-Aminobenzylpenicillin sodium salt, cell culture grade |
D-(-)-alpha-Aminopenicillin |
D-(-)-Ampicillin |
D-a-Aminobenzylpenicillin |
D-Ampicillin |
D-Cillin |
D(-)-alpha-Aminobenzylpenicillin sodium salt |
D00204 |
D02119 |
DB00415 |
degrees +/-UEthCaA(1)EO AAENI |
Delcillin |
Deripen |
Divercillin |
DivK1c_000466 |
Doktacillin |
Domicillin |
DSSTox_CID_2602 |
DSSTox_GSID_22602 |
DSSTox_RID_76654 |
DTXSID4022602 |
Duphacillin |
EC 200-709-7 |
EINECS 200-708-1 |
EINECS 200-709-7 |
Epitope ID:115008 |
Epitope ID:116057 |
FT-0602848 |
Grampenil |
Guicitrina |
Guicitrine |
HI 63 |
HMS1920C21 |
HMS2090I11 |
HMS2091I21 |
HMS2232J12 |
HMS2233H23 |
HMS501H08 |
HSDB 3009 |
HY-B0522 |
HY-B0522A |
IDI1_000466 |
JFN36L5S8K |
K161 |
KBio1_000466 |
KBio2_000430 |
KBio2_002998 |
KBio2_005566 |
KBio3_001362 |
KBioGR_000598 |
KBioSS_000430 |
KLOHDWPABZXLGI-YWUHCJSESA-M |
KS-R1 |
Lifeampil |
LS-1586 |
LS-169948 |
Marcillin |
MFCD00005175 |
MFCD00064313 |
MLS000028405 |
MLS000028726 |
MLS001074168 |
MolPort-001-794-635 |
MolPort-003-666-123 |
Monosodium (2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate |
Monosodium D-(-)-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate |
Morepen |
NCGC00018160-02 |
NCGC00023282-05 |
NCGC00023282-06 |
NCGC00178944-03 |
NCGC00248937-01 |
NCGC00255127-01 |
NINDS_000466 |
Norobrittin |
Novo-ampicillin |
NSC 528986 |
NSC-528986 |
NSC528986 |
Nuvapen |
Olin Kid |
Omnipen |
OMNIPEN (AMPICILLIN) |
Omnipen (TN) |
Omnipen-N |
Omnipen-N (TN) |
Opera_ID_1630 |
Opera_ID_709 |
Orbicilina |
P 50 |
P-50 |
Pen A |
Pen A Oral |
PEN A/N |
Pen Ampil |
Penbristol |
Penbritin |
Penbritin paediatric |
Penbritin syrup |
Penbritin-S |
Penbrock |
Penialmen |
Penicillin, (aminophenylmethyl)- |
Penicillin, Aminobenzyl |
Penicline |
Penimic |
Pensyn |
Pentrex |
Pentrexl |
Pentrexyl |
Pentritin |
Pfizerpen A |
Pfizerpen-A |
Polycillin |
Polycillin-N |
Polyflex (Veterinary) |
Ponecil |
Prestwick_822 |
Prestwick0_000114 |
Prestwick1_000114 |
Prestwick2_000114 |
Prestwick3_000114 |
Princillin |
Principen |
Principen '125' |
Principen '250' |
Principen '500' |
Principen/N |
QIDamp |
Racenacillin |
Ro-Ampen |
Rosampline |
Roscillin |
s3170 |
SAM002564243 |
SBB063111 |
SBI-0051283.P003 |
SCHEMBL3526 |
SCHEMBL40521 |
Semicillin |
Semicillin R |
Servicillin |
SK-Ampicillin |
SMP1_000211 |
SMR000058352 |
SMR000059229 |
Sodium (2S-(2alpha,5alpha,6beta(S*)))-6-(aminophenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate |
sodium (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
sodium (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
sodium (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
sodium 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylate |
Sodium amipicillin |
Sodium ampicillin |
sodium ampicillin(1-) |
Sodium binotal |
Sodium D-(-)-alpha-aminobenzylpenicillin |
Sodium P-50 |
sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
SPBio_000818 |
SPBio_002067 |
Spectrum_000050 |
SPECTRUM1500123 |
Spectrum2_000769 |
Spectrum3_000301 |
Spectrum4_000149 |
Spectrum5_000814 |
SQ 17382 |
ST077148 |
Sultamicillin EP Impurity C |
Sumipanto |
Supen |
SW220219-1 |
Synpenin |
Texcillin |
Tokiocillin |
Tolomol |
Totacillin |
Totacillin (sodium) |
Totacillin-N |
Totalciclina |
Totapen |
Tox21_113049 |
Tox21_113049_1 |
Tox21_301416 |
Trifacilina |
Ukapen |
Ultrabion |
Ultrabron |
UNII-7C782967RD |
UNII-JFN36L5S8K |
VA10275 |
VA10276 |
Vampen |
Viccillin |
Viccillin (TN) |
Viccillin S |
Vidocillin |
vidopen |
WY-5103 |
Wypicil |
ZINC3830218 |
ZX-AFC000780 |
US Patents and Regulatory Information for ampicillin sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 202197-001 | Apr 7, 2014 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Mylan Labs Ltd | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 201025-004 | Apr 9, 2014 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Bristol | POLYCILLIN-N | ampicillin sodium | INJECTABLE;INJECTION | 050309-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Pfizer | UNASYN | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 062901-002 | Feb 27, 1992 | AP | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
Mylan Labs Ltd | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 201024-001 | Apr 7, 2014 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.